Clinical Trials Browser

Colorectal Neoplasms, Microsatellite Instability

Esophageal Squamous Cell Carcinoma

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Stomach Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Head and Neck Neoplasms, Postoperative Complications

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

Pancreatic Neoplasms

Breast Cancer Female

Esophageal Neoplasms, Anastomotic Leak

Breast Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular

Agnosia, Delirium

Neoadjuvant Chemotherapy

Pancreatic Neoplasms

Pancreatic Neoplasms

Prostatic Neoplasms

Adenocarcinoma of Lung

Breast Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Rectal Neoplasms, Irritable Bowel Syndrome

Liver Neoplasms, Colorectal Neoplasms

Ovarian Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Prostate Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Ovarian Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Esophageal Neoplasms, Radiation Injuries

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Brain Neoplasms

Breast Neoplasms, Neovascularization, Pathologic

Rectal Neoplasms, Recurrence

Ovarian Neoplasms, Sarcoma, Desmoplastic Small Round Cell Tumor

Clinical Trials

ARETHUSA

SIGNAL 2

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Neo-CRAG

BoBCaT

SAKK 06/17

IP4-CHRONOS

POROMS

Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer

ESCC

Neo-DRATEC

CAP with NAT

Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients

Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Survival Analysis: TACE vs. Combination Therapy in HCC

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

Muscle Parameters and Pathological Response in Breast Cancer Patients

An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

SHIP0804

Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer

I-ONARC

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

NATCH

Long Term Bowel Function Following Rectal Cancer Surgery

Chemotherapy for Resectable Colorectal Liver Metastases

Short-course HIPEC in Advanced Epithelial Ovarian Cancer

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma

AADLPC

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

SCORPION

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer

Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS

BB'98

NEOZOL

Factors Predicting Recurrence in Rectal Cancer After Surgery

Combination Chemotherapy in Treating Patients With Sarcoma

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma